Cox Troy M.'s most recent trade in MapLight Therapeutics Inc. was a trade of 29,804 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MapLight Therapeutics Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 29,804 | 29,804 | - | - | Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 7,864 | 7,864 | - | 0 | Voting Common Stock | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 175,923 | 175,923 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 99,116 | 475,702 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 125,660 | 125,660 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 94,592 | 256,412 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 1.06 per share. | 28 Feb 2025 | 62,910 | 224,730 (0%) | 0% | 1.1 | 66,999 | Common Stock |
| Zymeworks BC Inc | Cox Troy M. | Director | 10 Dec 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | ||
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 72,213 | 72,213 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 43,128 | 161,820 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | M. Cox Troy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 982,811 | 982,811 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 190,365 | 190,365 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | M. Cox Troy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 184,999 | 184,999 | - | - | Warrant to purchase Common Stock (Right to buy) | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 87,057 | 87,057 (0%) | 0% | - | Common Stock | |
| Standard BioTools Inc | Cox Troy M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 79,412 | 166,469 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Troy Cox M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,842 | 51,842 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | M. Troy Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 31,635 | 198,104 (0%) | 0% | - | Common Stock | |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Zymeworks BC Inc | M. Troy Cox | Director | 07 Dec 2023 | 37,000 | 37,000 | - | - | Stock Option (Right to Buy) |